News
MHRA confirms supply of medical cannabis product until 2023
UK patients will be able to access the medical cannabis oil Celixir20 until the end of the year.
Search
24 results for “mhra”
Science
New MHRA guidance on real-world data a “step in the right direction”
New guidance, which appears to recognise the value of real-world evidence, has been welcomed by experts.
News
Cannabis Health Announces 2026 Symposium Series in Frankfurt and London
Europe’s dedicated medical cannabis education series for clinicians and industry professionals announces two autumn events — 4 November at Mainhaus, Frankfurt, and 26 November at Conway Hall, London
Industry
Ananda Pharma Confirms Safety of CBD Drug, as Clinical Pain Trials Approach
Ananda Pharma has taken another major step forward in bringing its flagship MRX1 CBD oral solution to market.
News
Curaleaf Laboratories and Herdade das Barrocas (HDB) Announce Strategic Partnership to Reintroduce HDB Products to the UK Medical Cannabis Market
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, […]
News
Cannabis-Based Drug Receives First European Market Approvals for Chronic Back Pain
Exilby® has received market authorisation in Germany and Austria, with UK approval expected by the end of the year.
News
Oliver’s Law: Campaign Calls for Changes to Medical Cannabis Prescribing in Psychiatric Conditions
A new campaign is calling for urgent regulatory changes to how medical cannabis is prescribed to psychiatric patients in the UK.
News
Ananda Pharma to Begin Dosing in NHS-Backed CBD Endometriosis Trial
The company has cleared the final regulatory hurdle to begin its ENDOCAN Phase 2 trial in women with endometriosis-associated pain.
Comment
Bridging the Gap: Medical Cannabis, Regulators, and the Reality of Clinical Accountability
Dr Sue Clenton, Consultant Oncologist and Medical Director at Releaf Cannabis Clinic, shares her insight from the front line of an emerging field of medicine.
Industry
113 Botanicals Launches £2m Raise to Bring Controlled-Release Cannabis Capsule to UK Patients
The company is preparing to reach a major regulatory milestone and bring its lead product to market in early 2026.
News
Europe’s First ‘Whole Plant’ Cannabis Medicine Could be Available by 2026
German pharmaceutical company Vertanical believes it is on course to deliver the first ‘whole-plant’, cannabis medicine with international approval. After seven years of endeavour, and an investment of over $250m, […]
Insight
Why Real-World Evidence is Key in Medical Cannabis Research
Is regulators’ focus on randomised controlled trials holding back progress in medical cannabis research?
Industry
Experts Publish New Guidelines for Best Practice in Prescribing Cannabis-Based Medicines
New guidelines aim to bring more clarity and consistency to the practice of prescribing cannabis-based medicines in the UK.
News
CQC Concerns Over Cannabis Prescribing Practices As Data Shows 130% Increase in Prescriptions
The issues raised have led to calls for a multi-agency review and clarification of the regulations.
Industry
FSA Publishes New Guidance On THC Limits And Recommended Daily Intake For CBD Products
The UK’s Food Standards Agency (FSA) has announced some significant updates to its multi-year CBD Novel Foods approvals process.
News
Much-Needed Or More Delays? UK Industry Responds to Upcoming ACMD Review of Cannabis-Based Medicines
The Advisory Council on the Misuse of Drugs (ACMD) will carry out a formal review of the regulatory framework around cannabis-based medicinal products.
Medical cannabis
How Releaf’s Rigorous Training Programme Ensures Patient Care
As the UK’s fastest-growing medical cannabis clinic, Releaf is committed to not only addressing an unmet healthcare need but doing so in a safe and clinically responsible manner.
News
Closing the Gap: How Real-World Evidence Could Reshape UK Medical Cannabis Policy
UK medical cannabis clinic, Releaf, is investing in an ambitious new research programme to collect critical real-world evidence on the effects of medical cannabis treatments. Could it help bridge the […]
Industry
Dalgety Ships Its First Medical-Grade Cannabis Flower in Milestone for UK Industry
The UK’s first fully-licensed EU-GMP medical cannabis cultivation facility launched its product earlier this month.
News
How Clinics Can Help Remove Professional Stigma Around Medical Cannabis
Cannabis clinics can play a crucial role in changing this landscape by setting high professional standards and ensuring patients receive the same level of care as with any other medical treatment.
News
Labour’s ‘Disappointing’ Response to Medical Cannabis Debate Show Nothing Has Changed
Via Business of Cannabis The first parliamentary debate on medical cannabis in the UK under the new Labour administration has shattered hopes of a more progressive stance on reform. Despite […]
News
What’s in Store for the European Cannabis Industry in 2025? (Part 2)
Written by Ben Stevens and Sarah Sinclair. You can read Part 1 here. Growing demand for medical cannabis across Europe Medical cannabis demand across Europe has seen substantial growth, particularly […]
Industry
Ananda Aiming to ‘Meet Regulators at Their Point of Need’ As it Secures More Major UK Clinical Cannabis Trials
Via Business of Cannabis UK-based biotech firm Ananda Developments has solidified its position as a driving force in clinical cannabis research in Europe, announcing the launch of two more major […]
News
NHS Accused Of “Failing Patients” As Families Make Fresh Plea For Access
Six years on from the legalisation of medical cannabis in the UK, new figures reveal lack of NHS prescribing.